Nyxoah develops and commercializes hypoglossal nerve stimulation therapy for the treatment of obstructive sleep apnea.
Business Model:
Revenue: $708.4k
Employees: 51-200
Address: Rue Edouard Belin 12
City: Mont-Saint-Guibert
State: walloon brabant
Zip: 1435
Country: BE
Nyxoah develops and commercializes hypoglossal nerve stimulation therapy for the treatment of obstructive sleep apnea.
Contact Phone:
+13210459075
Contact Email:
Listed Exchange:
NYSE
IPO Date:
7/2/2021
IPO Valuation:
$748M
Ticker Symbol:
NYXH
IPO Price:
$30/share
Amount Raised:
$85M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2018 | Series C | $0 |
Cochlear Cochlear Cochlear Cochlear |
7/2016 | Series B | 2 | $19.9M |
S.R.I.W. Gilde Healthcare Gilde Healthcare S.R.I.W. Gilde Healthcare Gilde Healthcare |
2/2020 | Corporate Round | $0 |
ResMed Cochlear ResMed Cochlear |
5/2014 | Series A | 1 | $10.9M |
Viralety Ventures Viralety Ventures Viralety Ventures Viralety Ventures |
9/2020 | IPO | $99M |
|
5/2014 | Series A | $11M | 7/2016 | Equity | $20M |
Glide Healthcare Novallia |
11/2018 | Equity | $17.1M |
Cochlear Limited |
2/2020 | Equity | $27.3M | 2/2020 | Corporate Round | 2 | $27.2M |
ResMed Cochlear ResMed Cochlear |
11/2018 | Series C | 1 | $16.8M |
Cochlear Cochlear Cochlear Cochlear |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|